Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins

Cardiovascular disease (CVD) risk in type 2 diabetes (T2DM) is only partially reduced by intensive glycemic control. Diabetic dyslipidemia is suggested to be an additional important contributor to CVD risk in T2DM. Multiple lipid lowering medications effectively reduce fasting LDL cholesterol and tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansar, Sameer, Koska, Juraj, Reaven, Peter D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184260/
https://www.ncbi.nlm.nih.gov/pubmed/21736746
http://dx.doi.org/10.1186/1475-2840-10-61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184260/
https://www.ncbi.nlm.nih.gov/pubmed/21736746
http://dx.doi.org/10.1186/1475-2840-10-61

Ejemplares similares